Refractory Burkholderia cepacia bacteraemia from a consolidation pneumonia lasting more than 7 weeks, successfully treated with systemic antibiotics and nebulised meropenem.

BMJ Case Reports
Bryan Albert LimJoseph Adrian Buensalido

Abstract

We present a case of a 55-year-old Filipino man who was transferred from another institution where he was recently diagnosed with Crohn's disease but not started on any immunosuppressants. He underwent laparoscopic cholecystectomy with T-tube placement a few weeks prior to admission. On workup, abdominal CT scan was unremarkable, but blood cultures on the third hospital day grew Burkholderia cepacia Antibiotic regimen was shifted to ceftazidime and levofloxacin. The bacteraemia and febrile episodes persisted despite removal of the central line and T tube. White blood cell scan and chest CT scan showed left-sided consolidation pneumonia. Blood cultures continued to grow B. cepacia despite shifting to meropenem and trimethoprim-sulfamethoxazole. Meropenem nebulisation at 250 mg every 12 hours was added to the regimen on the third week then oral minocycline was added on the fourth week due to persistence of bacteraemia. He subsequently developed a small vegetation on the aortic valve, so amikacin was added. Fever lysed on the sixth week, but the B. cepacia bacteraemia persisted, clearing only on the 51st hospital day. The patient was discharged with a plan to continue antibiotics, including meropenem nebulisation, for 6 more weeks...Continue Reading

References

Nov 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M PujolF Gudiol
May 15, 1996·American Journal of Epidemiology·M Corey, V Farewell
Apr 29, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·D A BelchisT Colby
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher W WoodsKeith S Kaye
Jun 29, 2004·The European Respiratory Journal·K De BoeckUNKNOWN Belgian Burkholderia cepacia Study Group
Sep 3, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Srinivasan RamanujaRobert P Nelson
Jul 22, 2006·BMC Microbiology·Paola GuglierameGiovanna Riccardi
Jul 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Adam M BresslerChristopher W Woods
Mar 22, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·A WeidmannA M Jones
Jul 4, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L DalesS D Aaron
Oct 1, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P Drevinek, E Mahenthiralingam
Feb 10, 2011·Indian Journal of Medical Microbiology·V GautamP Ray
Sep 6, 2011·Scandinavian Journal of Infectious Diseases·Nam Su KuJune Myung Kim
May 4, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Francis J GilchristAndrew M Jones
Jun 14, 2014·The European Respiratory Journal·Alessandra Monteiro BrodtLinjie Zhang
Apr 1, 2015·Enfermedades infecciosas y microbiología clínica·Carmen Montaño-RemachaFrancisco de Paula Téllez-Pérez
Aug 13, 2015·Indian Journal of Pediatrics·Liz Mary PaulSuchitra Shenoy
Sep 12, 2015·Case Reports in Infectious Diseases·Naomi Hauser, Jose Orsini
May 27, 2016·Clinical Microbiology Reviews·Eric WenzlerLarry H Danziger
Nov 5, 2016·International Journal of Antimicrobial Agents·Felicity K AbbottIan M Gould
Nov 3, 2016·The Cochrane Database of Systematic Reviews·Kate H Regan, Jayesh Bhatt
May 18, 2017·Journal of Clinical and Diagnostic Research : JCDR·Ritesh RanjanAman Kamra
Nov 26, 2018·International Journal of Antimicrobial Agents·Aaron J HeffernanJason A Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.